Acurx Pharmaceuticals LLC   Report issue

For profit Phase 2
Founded: White Plains NY United States (2017)

Organization Overview

First Clinical Trial
2020
NCT04247542
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Acurx Pharmaceuticals LLC

Active Ingredients

Drugs in Phase 2 Trials (1)

Ibezapolstat (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Clostridium Infections (Phase 2)

Communicable Diseases (Phase 2)

Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1